The current PE ratio of ORGO cannot be calculated, as the latest EPS of -$0.06 is negative. The most recent PE ratio recorded for Organogenesis Holdings was 71.0 in March 2024.
Over the last four years, the average PE ratio of Organogenesis Holdings has been 34.05. Analyzing the last four years, ORGO's PE ratio reached its highest point in the Dec 2023 quarter at 102.25, with a price of $4.09 and an EPS of $0.04. The Sep 2022 quarter saw the lowest point at 7.2, with a price of $3.24 and an EPS of $0.45.
Maximum annual increase: 356.07% in 2023
Maximum annual decrease: -73.1% in 2021
Year | PE ratio | Change |
---|---|---|
2023 | 102.25 | 356.07% |
2022 | 22.42 | 77.09% |
2021 | 12.66 | -73.1% |
2020 | 47.06 | N/A |
2019 | N/A | N/A |
2018 | N/A | N/A |
2017 | N/A | N/A |
2016 | N/A | N/A |
Stock name | PE ratio | Market cap |
---|---|---|
OPTN OptiNose Inc | N/A | $57.44M |
OPK Opko Health Inc | N/A | $1.03B |
ORGO Organogenesis Holdings Inc | N/A | $421.59M |
The current price to earnings ratio of ORGO cannot be determined, as its EPS of -$0.06 is negative.
Over the last 3 years, the average PE ratio for ORGO stock is 32.9.
Over the last 5 years, the average PE ratio for ORGO stock is 34.05.
Over the last four years, the Dec 2023 quarter recorded the highest quarterly PE ratio at 102.25.
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from and Sharadar.